127 related articles for article (PubMed ID: 10889923)
1. Isolation and characterisation of adenoid squamous carcinoma cells highly producing SCC antigen and CEA from carcinoma of the maxillary sinus.
Kishimoto H; Urade M; Sakurai K; Noguchi K
Oral Oncol; 2000 Jan; 36(1):70-5. PubMed ID: 10889923
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an esophageal squamous cell carcinoma tumor line and development of serum squamous cell carcinoma-related antigen in athymic nude mice.
Terashima M; Ikeda K; Ishida K; Saito K
J Surg Oncol; 1990 Aug; 44(4):225-8. PubMed ID: 2200926
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SCC antigen and cyclins in an adenoid squamous carcinoma cell line derived from the maxillary sinus.
Kishimoto H; Urade M; Hashimoto-Tamaoki T; Furuyama JI
Int J Oncol; 2001 Feb; 18(2):297-303. PubMed ID: 11172595
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.
Body JJ; Sculier JP; Raymakers N; Paesmans M; Ravez P; Libert P; Richez M; Dabouis G; Lacroix H; Bureau G
Cancer; 1990 Apr; 65(7):1552-6. PubMed ID: 2311066
[TBL] [Abstract][Full Text] [Related]
5. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
6. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
[TBL] [Abstract][Full Text] [Related]
7. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
[TBL] [Abstract][Full Text] [Related]
8. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
12. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
[TBL] [Abstract][Full Text] [Related]
13. [Establishment and characterization of a new SCC antigen producing cell line (HCS-2) from a carcinoma of the uterine cervix].
Morisawa T; Kuramoto H; Shimoda T; Sakamoto I; Kato Y; Hamano M
Hum Cell; 1988 Sep; 1(3):308-14. PubMed ID: 2979208
[TBL] [Abstract][Full Text] [Related]
14. [The clinical signifinace of CEA, Cyfra21-1 and SCC in laryngeal carcinoma's clinicopathological parameters].
Rao LH; Zhang L; Tian L; Yan JR; Xiang XY; Yu FB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1182-1186. PubMed ID: 29798354
[No Abstract] [Full Text] [Related]
15. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer.
Picardo AL; Torres AJ; Maestro M; Ortega D; Garcia-Asenjo JA; Mugüerza JM; Hernando F; Diez M; Balibrea JL
Cancer; 1994 May; 73(9):2305-11. PubMed ID: 8168034
[TBL] [Abstract][Full Text] [Related]
18. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
19. Utility of squamous cell carcinoma antigen (SCC Ag) as a tumour marker in pulmonary malignancy.
Upham J; Campbell B
Respir Med; 1992 May; 86(3):201-3. PubMed ID: 1620906
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer.
Niklinski J; Furman M; Laudanski J; Kozlowski M
Eur J Cancer Prev; 1992 Oct; 1(6):401-6. PubMed ID: 1334443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]